Table 1 Comparison of clinical and demographic data between patients with a MBL level above or below the median
|  | MBL < 722 ug/L | MBL >722 ug/L |
|---|---|---|
|  | N = 49 | N = 49 |
Age (years) | 45.3 ± 13.0 | 41.6 ± 12.4 |
ESRD (months) | 29 (0–168) | 33 (0–120) |
Dialysis status: | Â | Â |
Haemodialysis (N) | 34 | 32 |
Peritoneal dialysis (N) | 13 | 13 |
Pre-dialysis (N) | 2 | 4 |
Haemodialysis, venous access: Arterio-venous fistulae/permanently haemodialysis catheter (N) | 15/19 | 15/17 |
Tx status (living donor/deceased donor) | 22/27 | 26/23 |
Myocardial infarction (N) | 2 | 2 |
Smoking (N) | 15 | 14 |
Stroke (N) | 3 | 2 |
Diabetes (N) | 3 | 5 |
Impaired fasting glucose (N) | 1 | 2 |
Impaired glucose tolerance (N) | 21 | 13 |
Normal glucose tolerance (N) | 24 | 29 |
Fasting plasma glucose (mmol/L) | 5.0 ± 0.4 | 5.1 ± 0.5 |
OGTT 120min(mmol/L) | 8.0 ± 2.1 | 7.7 ± 2.1 |
ISI (index) | 7.4 ± 4.1 | 7.9 ± 4.9 |
BMI (kg/m2) | 24.2 ± 3.8 | 24.5 ± 3.6 |
PWV (m/s) | 8.2 (5.6-15.8) | 6.8 (5.2-16.4)* |
AIX (%) | 27 (-10;56) | 20 (-7;50) |
FMD (%) | 3.8 (-8.3;19.2) | 3.5 (-6.8;19.1) |
NID (%) | 10.5 (2.9;27.1) | 11.5 (2.0;27.2) |
Systolic blood pressure (mmHg) | 143 ± 25 | 140 ± 19 |
Diastolic blood pressure (mmHg) | 85 ± 12 | 84 ± 13 |
Number of antihypertensive drugs | 2 (0–5) | 3 (0–6)* |
P-C-reactive protein (mg/L) | 2 (1–40) | 2 (1–21) |
P-Homocystein (umol/L) | 21 (11–62) | 22 (12–150) |
P-PTH (pmol/L) | 21 (2–100) | 20 (4–156) |
P-ionized calcium (mmol/L) | 1.19 ± 0.09 | 1.21 ± 0.09 |
P-phosphate (mmol/L) | 1.8 ± 0.4 | 2.0 ± 0.6 |